Compounded Medications as Treatment Complexity Evidence in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

When a PI plaintiff requires compounded medications -- custom-formulated preparations not available as commercial products -- it documents that commercially available medications were insufficient. Compounding is evidence of treatment complexity and refractory conditions that strengthens demand packages.

A compounded medication is a custom-formulated pharmaceutical preparation created by a compounding pharmacy to meet a specific patient need that commercially manufactured medications cannot address. When a personal injury plaintiff requires compounded medications, it is clinical evidence that the standard pharmacological toolkit has been exhausted or is inadequate for their condition -- the injury is complex enough to require medications that do not exist in commercially available form.

• Compounded medications are prescribed when commercially available drugs are insufficient, unavailable in the needed formulation, or contraindicated for the specific patient
• The decision to compound is a clinical escalation that documents treatment complexity beyond what standard prescriptions can manage
• LienScripts coordinates compounded medication access through its platform, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report documenting why compounding was necessary and what it represents clinically
• Defense counsel cannot argue that standard treatment was sufficient when the prescriber specifically ordered a custom formulation because standard options failed
• Compounded medications often combine multiple active ingredients into a single preparation, documenting multi-mechanism pain that requires combination therapy

Why Compounding Is Prescribed in PI Cases

Compounding becomes necessary in personal injury pharmacotherapy for several clinical reasons:

Standard Medications Failed or Were Not Tolerated

The most common reason for compounding in PI cases is that the plaintiff tried commercially available medications and either found them ineffective or experienced intolerable side effects. When oral NSAIDs cause GI problems, a compounded topical pain cream containing an NSAID, an anesthetic, and a neuropathic agent may be prescribed to provide local relief without systemic side effects.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "When I see a compounding order for a PI patient, it tells me the prescriber has moved beyond the standard formulary. A compounded topical pain cream containing ketamine, gabapentin, and diclofenac in a single preparation is not a first-line treatment -- it is what happens when oral gabapentin alone was not enough, oral diclofenac caused GI issues, and the patient needs targeted pain relief at the injury site. The compounding order itself documents the treatment failures that led to this point."

Route of Administration Needs

Some plaintiffs cannot take oral medications effectively -- due to GI complications, swallowing difficulties from cervical injuries, or other factors. Compounding can provide the same active ingredients via topical, transdermal, sublingual, or rectal routes. The need for an alternative route of administration is itself evidence of the complexity and severity of the plaintiff's condition.

Combination Therapy in a Single Preparation

Compounded medications frequently combine multiple active ingredients that address different pain mechanisms simultaneously. A single compounded cream might contain:

• An NSAID (diclofenac or ketoprofen) for inflammation
• An anesthetic (lidocaine or prilocaine) for acute pain
• A neuropathic agent (gabapentin or amitriptyline) for nerve pain
• A muscle relaxant (cyclobenzaprine or baclofen) for spasm

Each ingredient in the compound targets a different aspect of the plaintiff's pain, documenting that the injury produces multi-mechanism pain requiring multi-agent treatment.

Allergen-Free or Sensitivity-Modified Formulations

When a plaintiff is allergic to inactive ingredients (dyes, preservatives, fillers) in commercially available medications, compounding provides allergen-free alternatives. This need documents that standard medications are not merely ineffective but pharmacologically inaccessible to the plaintiff.

Compounding as Exhaustion Evidence

The progression to compounded medications is typically the end point of a treatment escalation pathway:

1. First-line commercial medications tried and found insufficient
2. Second-line commercial medications tried and found insufficient or not tolerated
3. Dose escalation to maximum doses without adequate relief
4. Compounding -- the prescriber determines that no commercially available product meets the patient's need

This pathway, documented in pharmacy fill records, shows systematic exhaustion of standard options. The MERIT report from LienScripts presents this escalation timeline with clinical commentary explaining each step and why compounding became necessary.

Presenting Compounded Medication Evidence in Demand Packages

Include compounding evidence in every demand package where compounded medications were prescribed:

1. The compounded formulation -- listing all active ingredients and their concentrations
2. Clinical rationale -- why each ingredient was included and what pain mechanism it addresses
3. Prior treatment failures -- documenting the commercial medications tried before compounding was ordered
4. Treatment timeline -- showing when in the treatment course compounding became necessary
5. Multi-mechanism pain documentation -- explaining what the compound's ingredient list reveals about the complexity of the plaintiff's pain condition

Compounding and Treatment Complexity Arguments

Each Ingredient Tells a Story

Every active ingredient in a compounded preparation was included for a clinical reason. A compound with four active ingredients documents four distinct aspects of the plaintiff's condition that each require pharmacological treatment. This is a powerful complexity argument -- the plaintiff's pain is so multifaceted that no single commercially available medication can address it.

Compounding Demonstrates Prescriber Effort

Compounding requires additional effort from the prescriber: evaluating the patient's needs, determining that commercial options are inadequate, selecting appropriate compounds and concentrations, and writing a custom prescription. This effort documents the prescriber's clinical determination that the plaintiff's condition requires individualized pharmacotherapy.

Countering Defense Arguments

"Compounded medications are unproven."

While individual compounded preparations may not undergo the same FDA approval process as commercial medications, the individual active ingredients are FDA-approved drugs with established efficacy. The prescriber is combining proven ingredients in a custom formulation tailored to the patient's specific needs -- a standard practice in clinical pharmacy.

"Compounding is unnecessarily expensive."

The relevant question is not expense but clinical necessity. The prescriber ordered a compounded medication because commercial alternatives were inadequate. LienScripts ensures that compounding decisions are clinically justified and documented, and the medication class exhaustion pathway leading to compounding is captured in the pharmacy record.

Practical Takeaways

Compounded medications are clinical evidence that a plaintiff's injury is too complex for standard pharmacotherapy. Every compounding order represents a prescriber's clinical judgment that commercially available medications cannot adequately treat the plaintiff's condition. Attorneys who present compounding evidence systematically -- documenting the escalation pathway, the multi-ingredient formulation, and the clinical rationale -- add a powerful dimension of treatment complexity to their demand packages.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes compounded medication analysis with clinical context.

Related Resources

• Medication Class Exhaustion: Treatment Dead End -- When entire drug classes are insufficient
• Compound Medications in Personal Injury -- Overview of compounding in PI pharmacotherapy
• What Is a MERIT Report? -- Understanding the pharmacist-authored clinical summary